Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma Table 1. Comparison of Clinical ...
Lowering blood pressure to normal levels -- below currently recommended levels -- did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results